Profusa (PFSA) Shares Outstanding (Weighted Average) (2021 - 2026)
Profusa (PFSA) reported Shares Outstanding (Weighted Average) of $7.3 million for Q1 2026, up 28330.2% on a YoY basis from N/an in Q1 2025, and down 58.1% quarter-over-quarter from $17.5 million in Q4 2025.
Profusa (PFSA) Shares Outstanding (Weighted Average) (2021 - 2026) Analysis & Trends
Profusa has reported Shares Outstanding (Weighted Average) for 6 years, with the latest figure at $7.3 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 28330.2% year-over-year to $7.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.3 million (up 28330.2% YoY), and the FY2025 full-year result was $334762.0, up 1195.32% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $7.3 million, down from $17.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $31.7 million in Q3 2025, with the low at $25844.0 in Q4 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $6.8 million across 5 years, with a median of $5.2 million in 2022.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) sank 99.5% — and 2025, when it surged 67756.18%.
- Profusa's Shares Outstanding (Weighted Average) stood at $5.2 million in 2022, then changed by 0.0% to $5.2 million in 2023, then slumped by 99.5% to $25844.0 in 2024, then surged by 67756.18% to $17.5 million in 2025, then tumbled by 58.1% to $7.3 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $7.3 million (Q1 2026), $17.5 million (Q4 2025), and $31.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Profusa | 1.37 Mn | 1.37 Mn | - | 7.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.35 Mn |
| Dec 31, 2025 | 17.54 Mn |
| Sep 30, 2025 | 31.73 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | 25,844.00 |
| Dec 31, 2024 | 25,844.00 |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 5.19 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 5.19 Mn |
| Sep 30, 2022 | 5.19 Mn |
| Jun 30, 2022 | 5.19 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | 4.17 Mn |